Nanoparticle-Based Adjuvants and Delivery Systems for Modern Vaccines

Ever since the development of the first vaccine, vaccination has had the great impact on global health, leading to the decrease in the burden of numerous infectious diseases. However, there is a constant need to improve existing vaccines and develop new vaccination strategies and vaccine platforms t...

Full description

Bibliographic Details
Main Authors: Brankica Filipić, Ivana Pantelić, Ines Nikolić, Dragomira Majhen, Zorica Stojić-Vukanić, Snežana Savić, Danina Krajišnik
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/11/7/1172
_version_ 1797587291314585600
author Brankica Filipić
Ivana Pantelić
Ines Nikolić
Dragomira Majhen
Zorica Stojić-Vukanić
Snežana Savić
Danina Krajišnik
author_facet Brankica Filipić
Ivana Pantelić
Ines Nikolić
Dragomira Majhen
Zorica Stojić-Vukanić
Snežana Savić
Danina Krajišnik
author_sort Brankica Filipić
collection DOAJ
description Ever since the development of the first vaccine, vaccination has had the great impact on global health, leading to the decrease in the burden of numerous infectious diseases. However, there is a constant need to improve existing vaccines and develop new vaccination strategies and vaccine platforms that induce a broader immune response compared to traditional vaccines. Modern vaccines tend to rely on certain nanotechnology platforms but are still expected to be readily available and easy for large-scale manufacturing and to induce a durable immune response. In this review, we present an overview of the most promising nanoadjuvants and nanoparticulate delivery systems and discuss their benefits from tehchnological and immunological standpoints as well as their objective drawbacks and possible side effects. The presented nano alums, silica and clay nanoparticles, nanoemulsions, adenoviral-vectored systems, adeno-associated viral vectors, vesicular stomatitis viral vectors, lentiviral vectors, virus-like particles (including bacteriophage-based ones) and virosomes indicate that vaccine developers can now choose different adjuvants and/or delivery systems as per the requirement, specific to combatting different infectious diseases.
first_indexed 2024-03-11T00:35:04Z
format Article
id doaj.art-4113ceb0085b4d1a9c0f786f76c60918
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-11T00:35:04Z
publishDate 2023-06-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-4113ceb0085b4d1a9c0f786f76c609182023-11-18T21:40:41ZengMDPI AGVaccines2076-393X2023-06-01117117210.3390/vaccines11071172Nanoparticle-Based Adjuvants and Delivery Systems for Modern VaccinesBrankica Filipić0Ivana Pantelić1Ines Nikolić2Dragomira Majhen3Zorica Stojić-Vukanić4Snežana Savić5Danina Krajišnik6Department of Microbiology and Immunology, University of Belgrade-Faculty of Pharmacy, 11000 Belgrade, SerbiaDepartment of Pharmaceutical Technology and Cosmetology, University of Belgrade-Faculty of Pharmacy, 11000 Belgrade, SerbiaDepartment of Pharmaceutical Technology and Cosmetology, University of Belgrade-Faculty of Pharmacy, 11000 Belgrade, SerbiaDivision of Molecular Biology, Ruđer Bošković Institute, 10000 Zagreb, CroatiaDepartment of Microbiology and Immunology, University of Belgrade-Faculty of Pharmacy, 11000 Belgrade, SerbiaDepartment of Pharmaceutical Technology and Cosmetology, University of Belgrade-Faculty of Pharmacy, 11000 Belgrade, SerbiaDepartment of Pharmaceutical Technology and Cosmetology, University of Belgrade-Faculty of Pharmacy, 11000 Belgrade, SerbiaEver since the development of the first vaccine, vaccination has had the great impact on global health, leading to the decrease in the burden of numerous infectious diseases. However, there is a constant need to improve existing vaccines and develop new vaccination strategies and vaccine platforms that induce a broader immune response compared to traditional vaccines. Modern vaccines tend to rely on certain nanotechnology platforms but are still expected to be readily available and easy for large-scale manufacturing and to induce a durable immune response. In this review, we present an overview of the most promising nanoadjuvants and nanoparticulate delivery systems and discuss their benefits from tehchnological and immunological standpoints as well as their objective drawbacks and possible side effects. The presented nano alums, silica and clay nanoparticles, nanoemulsions, adenoviral-vectored systems, adeno-associated viral vectors, vesicular stomatitis viral vectors, lentiviral vectors, virus-like particles (including bacteriophage-based ones) and virosomes indicate that vaccine developers can now choose different adjuvants and/or delivery systems as per the requirement, specific to combatting different infectious diseases.https://www.mdpi.com/2076-393X/11/7/1172nanoadjuvantsnanoemulsionsviral-vectored systemvirus-like particles
spellingShingle Brankica Filipić
Ivana Pantelić
Ines Nikolić
Dragomira Majhen
Zorica Stojić-Vukanić
Snežana Savić
Danina Krajišnik
Nanoparticle-Based Adjuvants and Delivery Systems for Modern Vaccines
Vaccines
nanoadjuvants
nanoemulsions
viral-vectored system
virus-like particles
title Nanoparticle-Based Adjuvants and Delivery Systems for Modern Vaccines
title_full Nanoparticle-Based Adjuvants and Delivery Systems for Modern Vaccines
title_fullStr Nanoparticle-Based Adjuvants and Delivery Systems for Modern Vaccines
title_full_unstemmed Nanoparticle-Based Adjuvants and Delivery Systems for Modern Vaccines
title_short Nanoparticle-Based Adjuvants and Delivery Systems for Modern Vaccines
title_sort nanoparticle based adjuvants and delivery systems for modern vaccines
topic nanoadjuvants
nanoemulsions
viral-vectored system
virus-like particles
url https://www.mdpi.com/2076-393X/11/7/1172
work_keys_str_mv AT brankicafilipic nanoparticlebasedadjuvantsanddeliverysystemsformodernvaccines
AT ivanapantelic nanoparticlebasedadjuvantsanddeliverysystemsformodernvaccines
AT inesnikolic nanoparticlebasedadjuvantsanddeliverysystemsformodernvaccines
AT dragomiramajhen nanoparticlebasedadjuvantsanddeliverysystemsformodernvaccines
AT zoricastojicvukanic nanoparticlebasedadjuvantsanddeliverysystemsformodernvaccines
AT snezanasavic nanoparticlebasedadjuvantsanddeliverysystemsformodernvaccines
AT daninakrajisnik nanoparticlebasedadjuvantsanddeliverysystemsformodernvaccines